Compare IX & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IX | GEHC |
|---|---|---|
| Founded | 1950 | 1892 |
| Country | Japan | United States |
| Employees | 51921 | N/A |
| Industry | Diversified Financial Services | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4B | 32.1B |
| IPO Year | N/A | 2022 |
| Metric | IX | GEHC |
|---|---|---|
| Price | $31.87 | $74.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $89.23 |
| AVG Volume (30 Days) | 370.4K | ★ 3.0M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.35% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $11.91 | $7.12 |
| Revenue Next Year | $4.50 | $4.45 |
| P/E Ratio | ★ $12.93 | $16.40 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $19.79 | $60.83 |
| 52 Week High | $37.04 | $89.77 |
| Indicator | IX | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 52.56 |
| Support Level | $29.29 | $69.59 |
| Resistance Level | $37.04 | $74.83 |
| Average True Range (ATR) | 0.50 | 1.67 |
| MACD | 0.30 | 0.61 |
| Stochastic Oscillator | 80.99 | 74.34 |
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).